ACTRN12622001495718
Not yet recruiting
未知
Prevention and treatment of chemotherapy induced nausea and vomiting using music therapy interventions for people undergoing medium or high risk emetogenic chemotherapy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Flinders Foundation
- Enrollment
- 24
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Participants who are planned to undergo systemic therapy for their cancer with regimen that are medium emetogenic chemotherapy (MEC) or highly emetogenic chemotherapy.
- •2\.Capable of giving signed informed consent.
- •3\.Able to understand English.
Exclusion Criteria
- •1\.Previously have had chemotherapy
- •2\.Planned for or prior cranial radiotherapy
- •3\.Established cognitive impairment
- •4\.Significant baseline nausea and vomiting from cancer or other diseases such as bowel or gastric outlet obstruction
- •5\.Pregnant at study entry
- •6\.Known significant hearing impairment not corrected by hearing aids
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Hilotherapy for prevention of chemotherapy-induced peripheral polyneuropathy - A unicentric, prospective-controlled, randomized clinical trial for comparison of local hilotherapy vs. no therapy to prevent peripheral polyneuropathy during Taxan-based chemotherapy regimeG62.0C50.9C54C56C53Drug-induced polyneuropathyBreast, unspecifiedMalignant neoplasm of corpus uteriMalignant neoplasm of ovaryMalignant neoplasm of cervix uteriDRKS00027242niversitätsklinikum Ulm150
Not yet recruiting
Phase 3
sing medicine Fosaprepitant along with other anti-vomiting medications for better control of vomiting and nausea in children receiving chemotherapyCTRI/2023/12/060941Cancer Institute (WIA)
Unknown
Phase 3
preventing chemotherapy induced nausea and vomiting in children without using steroid (dexamethasone)Health Condition 1: C00-D49- NeoplasmsCTRI/2022/05/042750Cancer Institute
Completed
Phase 3
preventing chemotherapy induced nausea and vomiting without using steroid (dexamethasone)CTRI/2022/03/040906Cancer Institute350
Recruiting
Phase 3
Study to evaluate if vomiting due to chemotherapy in children and adolescents can be stopped without the use of steroid drug (dexamethasone).CTRI/2022/08/045009Cancer Institute